For research and educational purposes only. Not medical advice.
Urolithin A Reference
Educational, not medical advice reference for Urolithin A: Longevity; regulatory status, evidence posture, source review, and schedule notes. Al…
Plain English
- What it is
- Urolithin A is a compound your gut bacteria make when you digest certain foods like pomegranates, berries, and walnuts. It is sold over the counter as a dietary supplement, with the most-studied version being a brand called Mitopure. It is not an FDA-approved drug for any condition.
- What people use it for
- People interested in healthy aging take it hoping to support their mitochondria, the tiny power plants inside cells, and to help aging muscles. The main hope is better muscle strength, endurance, and overall cellular health.
- What the science shows
- Small randomized human trials in middle-aged and older adults reported better muscle endurance and improved lab markers of mitochondrial health, and early research found it appears safe and well tolerated. But those trials only measured short-term performance and blood markers, not long-term health. There is no large outcome trial, so longevity and anti-aging benefits remain unproven in people.
- The catch
- The early signals are interesting, but the human evidence is limited to surrogate markers (lab readouts and short tests), not proof that it helps people live longer or healthier over time. Because supplements are not regulated like approved drugs, quality and the actual amounts in a product can vary a lot from one maker to another. For research and educational purposes only. Not medical advice.
Reference summary
Andreux 2019 Nat Metab reported safety and a molecular signature of improved mitochondrial health in humans. Singh 2022 Cell Rep Med (middle-aged adults) and Liu 2022 JAMA Network Open (older adults) reported improvements in muscle endurance and mitochondrial biomarkers in randomized trials. All published human data are surrogate-marker; no Phase 3 outcome trial exists.
Regulatory and posture
- Categories
- Longevity
- Aliases
- UA, Mitopure (Amazentis brand), Ellagitannin metabolite (OTC dietary supplement)
- Evidence posture
- human - Surrogate-marker human RCTs only; no outcome trial.
- Regulatory status
- Over-the-counter dietary supplement in the United States. Urolithin A from Amazentis (sold under the Mitopure brand) received an FDA GRAS 'no questions' letter in December 2018 (GRN 791); GRAS designates safe-as-food, not approved-as-drug. Not FDA-approved as a drug for any indication.
- Content review status
- research reference
Selected public sources
- PubMed: Andreux et al. Nat Metab 2019 - urolithin A is safe and induces a molecular signature of improved mitochondrial health in humans (PMID 32694802)
- PubMed: Singh et al. Cell Rep Med 2022 - urolithin A improves muscle strength and exercise performance in middle-aged adults RCT (PMID 35584623)
- PubMed: Liu et al. JAMA Netw Open 2022 - urolithin A supplementation on muscle endurance and mitochondrial health in older adults RCT (PMID 35050355)